Abbott gets FDA nod for longer length Esprit BTK drug-eluting scaffold
July 13, 2026
Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.
Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.
SAN DIEGO, July 7, 2026 /PRNewswire/ — CliniComp, a pioneer in high-performing, reliable, electronic health record (EHR) solutions, announced FDA 510(k) clearance of its PACS (Picture Archiving and Communication System) Viewer as a Medical Image Management and Processing System (MIMPS).
To develop new and better peptides, the short amino acid strings behind medicines like GLP-1 drugs, researchers have used AI to generate candidates and to predict their properties.
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative.
Good sleep is essential for brain health. During sleep and rest, the glymphatic system, the brain’s waste-clearing process, helps remove metabolic waste that accumulates during waking hours.
Sanofi announced today that the FDA approved the delivery of its Sarclisa anticancer therapy through the Enable Injections on-body device.
Thread-based electronics that conform to the body could point toward softer, less obtrusive health monitors
Zeta Surgical announced today that it received FDA 510(k) clearance for its TMS Robotic System as a stereotaxic instrument.
Spiro Robotics earned FDA 510(k) clearance for its handheld, dual image-guided system for tracheal intubation, Spiro-VISTA.
A high-performance biodegradable pressure sensor has been developed as a key technology for wearable AI health care robotics and user-friendly robotic systems.